Singapore: ResMed has won an import ban in the US against a Taiwanese device manufacturer alleged to be infringing on the company's patents.

The ITC ruling states that APEX devices with infringing humidifiers cannot be imported or sold in the United States. ResMed will also ask the ITC to impose a fine on APEX for any infringing products sold in the US to date. ResMed first filed a complaint with the ITC in March 2013. In August 2013, APEX redesigned the flow generators in an attempt to stop the alleged patent infringements. But an ITC judge has held that APEX continues to infringe and that even the redesigned devices cannot be imported and sold in the market.

"There are hundreds of innovations that go into each ResMed therapy product, which is what elevates ResMed's product quality and therapy comfort from the rest of the pack," said Mr David Pendarvis, ResMed's chief administrative officer and global general counsel . "This ITC victory is validation that our customers should not accept imitations," he added. "We are confident that the commission will agree with the judge's decision and will continue to enforce our intellectual property against those who infringe it," he concluded.